14/05/2026
The ESG Revolution in Pharma: Sustainable Third-Party Manufacturing and Green PCD Franchises in Haryana (2026 Outlook)
Eco-compliant manufacturing and carbon-neutral supply chain logistics
As we navigate through 2026, the pharmaceutical landscape in India has shifted from simple volume-based production to a value-driven, sustainable ecosystem. The global push for Environmental, Social, and Governance (ESG) compliance has fundamentally altered how B2B partnerships are formed. For distributors and medical professionals looking to invest, the 'Green' movement in pharma is no longer a niche—it is the primary driver of high-margin growth.
https://sehwinhealthcare.com/blog/the-esg-revolution-in-pharma-sustainable-third-party-manufacturing-and-green-pcd-franchises-in-haryana-2026-outlook